Palonosetron (PALO) plus aprepitant (APREP) and dexamethasone (DEX) for the prevention of chemotherapy-induced nausea and vomiting (CINV) after emetogenic chemotherapy (CT)

被引：0
|
作者：
Grote, T
Hajdenberg, J
Cartmell, A
Ferguson, S
Ginkel, A
Gallagher, S
Charu, V
机构：
[1] Piedmont Hematol Oncol, Winston Salem, NC USA
[2] Pasco Pinellas Canc Ctr, Tarpon Springs, FL USA
[3] Comprehens Blood & Canc Inst, Bakersfield, CA USA
[4] Cooper Green Hosp, Birmingham, AL USA
[5] MGI Pharma, Bloomington, MN USA
[6] Pacific Canc Med Ctr, Anaheim, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8262
引用
下载
收藏
页码：794S / 794S
页数：1
相关论文
共 50 条
  • [31] Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adolescents
    Shiu, Jennifer R.
    Romanick, Marcel
    Stobart, Kent
    PEDIATRIC BLOOD & CANCER, 2009, 53 (07) : 1357 - 1357
  • [32] Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancer
    Bubalo, Joseph S.
    Herrington, Jon D.
    Takemoto, Marc
    Willman, Patricia
    Edwards, Michael S.
    Williams, Casey
    Fisher, Alan
    Palumbo, Alison
    Chen, Eric
    Blanke, Charles
    Lopez, Charles D.
    SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1273 - 1279
  • [33] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
    Miya, Toshimichi
    Kobayashi, Kunihiko
    Hino, Mitsunori
    Ando, Masahiro
    Takeuchi, Susumu
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    SPRINGERPLUS, 2016, 5
  • [34] Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Longo, Flavia
    Mansueto, Giovanni
    Lapadula, Vittoria
    De Sanctis, Rita
    Quadrini, Silvia
    Grande, Roberta
    Gori, Bruno
    Altavilla, Amelia
    D'Antoni, I.
    Del Signore, Ester
    Stumbo, Luciano
    De Luca, Cristina
    Cimadon, Barbara
    Cortesi, Enrico
    Gamucci, Teresa
    Di Seri, Marisa
    SUPPORTIVE CARE IN CANCER, 2011, 19 (08) : 1159 - 1164
  • [35] Netupitant/palonosetron (NEPA) for prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in multiple cycles of chemotherapy.
    Schwartzberg, Lee Steven
    Gralla, Richard J.
    Kashef, Kimia
    Rugo, Hope
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [36] Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients
    Kitamura, Hiroshi
    Takahashi, Atsushi
    Hotta, Hiroshi
    Kato, Ryuichi
    Kunishima, Yasuharu
    Takei, Fumiyasu
    Horita, Hiroki
    Masumori, Naoya
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (10) : 911 - 914
  • [37] Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy
    Flavia Longo
    Giovanni Mansueto
    Vittoria Lapadula
    Rita De Sanctis
    Silvia Quadrini
    Roberta Grande
    Bruno Gori
    Amelia Altavilla
    I. D’Antoni
    Ester Del Signore
    Luciano Stumbo
    Cristina De Luca
    Barbara Cimadon
    Enrico Cortesi
    Teresa Gamucci
    Marisa Di Seri
    Supportive Care in Cancer, 2011, 19 : 1159 - 1164
  • [38] ASSOCIATION OF APREPITANT AND PALONOSETRON IN PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING IN HIGH EMETOGENIC CHEMOTHERAPY REGIMENS
    Livi, L.
    Meattini, I.
    Francolini, G.
    Scotti, V.
    Cappelli, S.
    Desideri, I.
    Cardillo, C. De Luca
    ANNALS OF ONCOLOGY, 2014, 25
  • [39] Palonosetron (PALO) versus granisetron (GRA) in the triplet regimen with dexamethasone (DEX) and aprepitant (APR) for preventing chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving highly emetogenic chemotherapy (HEC) with cisplatin (CDDP): A randomized, double-blind, phase III trial.
    Hashimoto, Hironobu
    Yamanaka, Takeharu
    Shimada, Yasuhiro
    Arata, Koji
    Matsui, Reiko
    Goto, Koichi
    Takiguchi, Tomomi
    Ohyanagi, Fumiyoshi
    Kogure, Yuki
    Nogami, Naoyuki
    Nakao, Masahiko
    Takeda, Koji
    Azuma, Kanako
    Nagase, Seisuke
    Hayashi, Toshinobu
    Fujiwara, Kimiko
    Shimada, Toshikazu
    Seki, Nobuhiko
    Suzuki, Kenichi
    Yamamoto, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy.
    Miya, Toshimichi
    Kobayashi, Kunihiko
    Hino, Mitsunori
    Ando, Masahiro
    Takeuchi, Susumu
    Seike, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
12345